• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从废水中分离出的一种噬菌体在治疗小鼠肺炎克雷伯菌引起的大叶性肺炎感染中的潜力。

Potential of a Bacteriophage Isolated from Wastewater in Treatment of Lobar Pneumonia Infection Induced by Klebsiella pneumoniae in Mice.

作者信息

Soleimani Sasani Mahboubeh, Eftekhar Fereshteh

机构信息

Department of Microbiology and Microbial Biotechnology, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, G.C., Tehran, Iran.

出版信息

Curr Microbiol. 2020 Oct;77(10):2650-2655. doi: 10.1007/s00284-020-02041-z. Epub 2020 May 25.

DOI:10.1007/s00284-020-02041-z
PMID:32451685
Abstract

The potential of bacteriophages as alternative treatment for multidrug-resistant (MDR) Klebsiella pneumoniae-related infections has recently gained much interest. The purpose of this research was to isolate and characterize a K. pneumoniae-specific lytic phage with the potential to treat experimental lobar pneumonia induced by K. pneumoniae in mice. A lytic phage was isolated from an urban wastewater sample in Tehran and characterized by transmission electron microscopy (TEM), thermal, pH, and chloroform stability before being employed for treatment of mice infected with K. pneumoniae in an experimental model of lobar pneumonia. BALB/C mice were challenged by intranasal inoculation with 10 colony-forming units (CFU/ml) of K. pneumoniae ATCC 10031 followed by an intraperitoneal injection of the isolated phage using 10 and 10 plaque-forming units (PFU/ml) simultaneously or 24 h post infection. Control groups of mice received bacteria or bacteriophage alone. Mice were euthanized daily up to 7 days post infection and examined for abnormality in their lungs and livers followed by determining the number of phages and bacteria in plasma and lung homogenates. The isolated phage (vB_KpnM-Teh.1) belonged to the Myoviridae family, was stable at 37 °C, pH 7, and was resistant to chloroform. Treatment of mice with a single dose of phage simultaneously at the time of infection, or 24 h post infection, resulted in seven and five logs decrease of CFU/ml in the lung homogenates up to 3 days after phage administration, respectively. The isolated phage may have the potential as a therapeutic agent against K. pneumoniae infections.

摘要

噬菌体作为耐多药(MDR)肺炎克雷伯菌相关感染替代治疗方法的潜力最近备受关注。本研究的目的是分离并鉴定一种肺炎克雷伯菌特异性裂解噬菌体,该噬菌体有潜力治疗小鼠实验性大叶性肺炎,该肺炎由肺炎克雷伯菌引起。从德黑兰城市污水样本中分离出一种裂解噬菌体,并通过透射电子显微镜(TEM)、热稳定性、pH稳定性和氯仿稳定性进行鉴定,然后将其用于在大叶性肺炎实验模型中治疗感染肺炎克雷伯菌的小鼠。BALB/C小鼠通过鼻内接种10个肺炎克雷伯菌ATCC 10031菌落形成单位(CFU/ml)进行攻毒,随后腹腔注射分离出的噬菌体,同时使用10和10个噬菌斑形成单位(PFU/ml)或在感染后24小时注射。小鼠对照组分别单独接受细菌或噬菌体。在感染后长达7天内每天对小鼠实施安乐死,并检查其肺部和肝脏是否异常,随后测定血浆和肺匀浆中的噬菌体和细菌数量。分离出的噬菌体(vB_KpnM-Teh.1)属于肌尾噬菌体科,在37°C、pH 7时稳定,且对氯仿有抗性。在感染时或感染后24小时用单剂量噬菌体治疗小鼠,分别导致在噬菌体给药后3天内肺匀浆中CFU/ml下降7个对数和5个对数。分离出的噬菌体可能有潜力作为治疗肺炎克雷伯菌感染的药物。

相似文献

1
Potential of a Bacteriophage Isolated from Wastewater in Treatment of Lobar Pneumonia Infection Induced by Klebsiella pneumoniae in Mice.从废水中分离出的一种噬菌体在治疗小鼠肺炎克雷伯菌引起的大叶性肺炎感染中的潜力。
Curr Microbiol. 2020 Oct;77(10):2650-2655. doi: 10.1007/s00284-020-02041-z. Epub 2020 May 25.
2
Therapeutic potential of bacteriophage in treating Klebsiella pneumoniae B5055-mediated lobar pneumonia in mice.噬菌体治疗小鼠肺炎克雷伯菌B5055介导的大叶性肺炎的治疗潜力。
J Med Microbiol. 2008 Dec;57(Pt 12):1508-1513. doi: 10.1099/jmm.0.2008/002873-0.
3
[Biological characteristics and genomic information of a bacteriophage against pan-drug resistant in a burn patient and its effects on bacterial biofilm].[烧伤患者中一株抗泛耐药菌噬菌体的生物学特性、基因组信息及其对细菌生物膜的影响]
Zhonghua Shao Shang Za Zhi. 2020 Jan 20;36(1):14-23. doi: 10.3760/cma.j.issn.1009-2587.2020.01.004.
4
Isolation and Characterization of vB_kpnM_17-11, a Novel Phage Efficient Against Carbapenem-Resistant .分离和鉴定 vB_kpnM_17-11,一种有效对抗碳青霉烯类耐药菌的新型噬菌体。
Front Cell Infect Microbiol. 2022 Jul 5;12:897531. doi: 10.3389/fcimb.2022.897531. eCollection 2022.
5
Evaluation of the efficacy of a bacteriophage in the treatment of pneumonia induced by multidrug resistance Klebsiella pneumoniae in mice.评估一种噬菌体对小鼠多药耐药肺炎克雷伯菌所致肺炎的治疗效果。
Biomed Res Int. 2015;2015:752930. doi: 10.1155/2015/752930. Epub 2015 Mar 23.
6
Isolation, Identification, and Biological Characterization of Phage vB_KpnM_KpVB3 Targeting Carbapenem-Resistant Klebsiella pneumoniae ST11.针对碳青霉烯类耐药肺炎克雷伯菌 ST11 的噬菌体 vB_KpnM_KpVB3 的分离、鉴定和生物学特性研究
J Glob Antimicrob Resist. 2024 Jun;37:179-184. doi: 10.1016/j.jgar.2024.03.007. Epub 2024 Mar 30.
7
Phage therapy for treatment of virulent Klebsiella pneumoniae infection in a mouse model.噬菌体疗法治疗小鼠毒力肺炎克雷伯菌感染。
J Glob Antimicrob Resist. 2020 Jun;21:34-41. doi: 10.1016/j.jgar.2019.09.018. Epub 2019 Oct 8.
8
Bacteriophage in the treatment of experimental septicemic mice from a clinical isolate of multidrug resistant Klebsiella pneumoniae.噬菌体对临床分离的多重耐药肺炎克雷伯菌所致实验性败血症小鼠的治疗作用
J Commun Dis. 2005 Mar;37(1):18-29.
9
Bacteriophage Effectively Rescues Pneumonia Caused by Prevalent Multidrug-Resistant in the Early Stage.噬菌体在早期有效拯救了普遍存在的多重耐药菌引起的肺炎。
Microbiol Spectr. 2022 Oct 26;10(5):e0235822. doi: 10.1128/spectrum.02358-22. Epub 2022 Sep 27.
10
Therapeutic Efficacy of Bacteriophage Therapy to Treat Carbapenem Resistant Klebsiella Pneumoniae in Mouse Model.噬菌体疗法治疗小鼠碳青霉烯类耐药肺炎克雷伯菌的疗效。
J Nepal Health Res Counc. 2021 Apr 23;19(1):76-82. doi: 10.33314/jnhrc.v19i1.3282.

引用本文的文献

1
Phage therapy for Klebsiella pneumoniae: Understanding bacteria-phage interactions for therapeutic innovations.肺炎克雷伯菌的噬菌体疗法:理解细菌与噬菌体的相互作用以实现治疗创新。
PLoS Pathog. 2025 Apr 8;21(4):e1012971. doi: 10.1371/journal.ppat.1012971. eCollection 2025 Apr.
2
Potential of a phage cocktail in the treatment of multidrug-resistant Klebsiella pneumoniae pulmonary infection in mice.噬菌体鸡尾酒疗法治疗小鼠耐多药肺炎克雷伯菌肺部感染的潜力
BMC Microbiol. 2025 Mar 17;25(1):151. doi: 10.1186/s12866-025-03851-6.
3
Pharmacokinetics and pharmacodynamics of bacteriophage therapy: a review with a focus on multidrug-resistant Gram-negative bacterial infections.
噬菌体治疗的药代动力学和药效学:综述,重点关注多药耐药革兰氏阴性细菌感染。
Clin Microbiol Rev. 2024 Sep 12;37(3):e0004424. doi: 10.1128/cmr.00044-24. Epub 2024 Jul 29.
4
Phage therapy: breathing new tactics into lower respiratory tract infection treatments.噬菌体疗法:为下呼吸道感染治疗注入新策略。
Eur Respir Rev. 2024 Jun 26;33(172). doi: 10.1183/16000617.0029-2024. Print 2024 Apr.
5
Plant-Origin Components: New Players to Combat Antibiotic Resistance in .植物源成分:应对抗生素耐药性的新武器
Int J Mol Sci. 2024 Feb 10;25(4):2134. doi: 10.3390/ijms25042134.
6
Therapeutic Bacteriophages for Gram-Negative Bacterial Infections in Animals and Humans.用于动物和人类革兰氏阴性菌感染的治疗性噬菌体
Pathog Immun. 2022 Oct 17;7(2):1-45. doi: 10.20411/pai.v7i2.516. eCollection 2022.
7
Characterization and Genomic Analysis of a Novel Drexlervirial Bacteriophage IME268 with Lytic Activity Against .一种对……具有裂解活性的新型德雷克斯勒病毒噬菌体IME268的特性鉴定与基因组分析
Infect Drug Resist. 2022 Apr 5;15:1533-1546. doi: 10.2147/IDR.S347110. eCollection 2022.
8
Pharmacokinetics and Pharmacodynamics of a Novel Virulent Klebsiella Phage Kp_Pokalde_002 in a Mouse Model.新型毒力肺炎克雷伯菌噬菌体 Kp_Pokalde_002 在小鼠模型中的药代动力学和药效学。
Front Cell Infect Microbiol. 2021 Aug 16;11:684704. doi: 10.3389/fcimb.2021.684704. eCollection 2021.
9
Phages from Ganges River curtail in vitro biofilms and planktonic growth of drug resistant Klebsiella pneumoniae in a zebrafish infection model.来自恒河的噬菌体在斑马鱼感染模型中可抑制耐药性肺炎克雷伯菌的体外生物膜形成和浮游生长。
AMB Express. 2021 Feb 15;11(1):27. doi: 10.1186/s13568-021-01181-0.
10
Characterization of four virulent Klebsiella pneumoniae bacteriophages, and evaluation of their potential use in complex phage preparation.鉴定四种毒力较强的肺炎克雷伯氏菌噬菌体,并评估其在复杂噬菌体制剂中的潜在应用。
Virol J. 2021 Jan 6;18(1):9. doi: 10.1186/s12985-020-01485-w.